Is this your firm? Get featured or correct your listing →
At a glance
Invus appears in 4 funding rounds tracked by ValueAddVC since 2026. Its most frequent sector in these rounds is Health & Biotech, and its most recent tracked deal was Universal Quantum's $100M+ Series A round (Oct 8, 2026).
Strategy
Recent changes
- Oct 8, 2026Oct 8, 2026Invested in Universal Quantum (Series A, $100M+) Tech Funding News
- Sep 24, 2026Sep 24, 2026Invested in Precision Neuroscience (Series D, $250M) GlobeNewswire
- Sep 9, 2026Sep 9, 2026Invested in Encoded Therapeutics (Series F, $275M) Encoded Therapeutics (Business Wire via BioSpace)
- Jun 30, 2026Jun 30, 2026Invested in Flare Therapeutics (Series C, $85M) GlobeNewswire
Portfolio
4 totalRecent Investment Activity
4Track record: led 0 and participated in 4 of 4 tracked venture rounds · 4 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Universal Quantum | Series A | Participated | $100M+ | — | Tech Funding News | |
| Sep 24, 2026 | Precision Neuroscience | Series D | Participated | $250M | ~$1B | Pershing SquareLeadunverifiedAckman Oxman InstituteLeadunverifiedDuquesne Family OfficeunverifiedB CapitalARK InvestInvusMubadala CapitalMirae Asset CapitalKorea Investment PartnersHitachi VenturesJSL Health Capital | GlobeNewswire |
| Sep 9, 2026 | Encoded Therapeutics | Series F | Participated | $275M | — | Google Ventures (GV)LeadARCH Venture PartnersIllumina VenturesInvusJanus Henderson InvestorsRTW InvestmentsSoftBank Vision FundVenrockBraidwellFarallon Capital ManagementMatrix Capital ManagementNolan Capital | Encoded Therapeutics (Business Wire via BioSpace) |
| Jun 30, 2026 | Flare Therapeutics | Series C | Participated | $85M | — | Pulse story |
Sector / Stage Activity
Co-Investors
12Similar Firms
overlapping sector, stage or regionInvus FAQ
What companies has Invus invested in?
Invus' portfolio includes Universal Quantum, Precision Neuroscience, Encoded Therapeutics, Flare Therapeutics.
Who does Invus co-invest with most?
In the rounds Value Add tracks, Invus most often invests alongside Ackman Oxman Institute (1 shared deal), ARCH Venture Partners (1 shared deal), ARK Invest (1 shared deal), ARK Investment Management (1 shared deal), B Capital (1 shared deal).
Sources & methodologyshow
- GlobeNewswireprimary source1 fact
- GlobeNewswireprimary source1 fact
- Encoded Therapeutics (Business Wire via BioSpace)research database1 fact
- Tech Funding NewsValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.